title: Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reduction.
authors.affiliation: Department of Respiratory Medicine, Oslo University Hospital, Norway.
authors.forename: May Brit
authors.initials: MB
authors.lastname: Lund
authors.forename: Vemund
authors.initials: V
authors.lastname: Paulsen
authors.forename: Pål
authors.initials: P
authors.lastname: Aukrust
mesh_terms: D000068338:Everolimus; D005260:Female; D006801:Humans; D007078:Ileal Neoplasms / Q000188:drug therapy*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007580:Jejunal Neoplasms / Q000188:drug therapy*; D016040:Lung Transplantation; D008875:Middle Aged; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus